Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Clinical Trial on Treatment of Intraventricular Hemorrhage

ClinicalTrials.gov ID: NCT00650858

Public ClinicalTrials.gov record NCT00650858. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (IVH)

Study identification

NCT ID
NCT00650858
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Johns Hopkins University
Other
Enrollment
52 participants

Conditions and interventions

Interventions

  • tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2004
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Dec 10, 2017

2004 – 2008

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
CR Drew Medical Center Los Angeles California 90059
Standford Medical Center Palo Alto California 94394
Hartford Hospital Hartford Connecticut 06102
Loyola University Medical Center Maywood Illinois 60153
Via Christi Regional Medical Center Wichita Kansas 67214
University of Maryland Medical Systems Baltimore Maryland 21202
Johns Hopkins University Baltimore Maryland 21287
Wayne State University Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
St. Louis University St Louis Missouri 63110
Albany Medical Center Albany New York 12208
Mt. Sinai Medical Center New York New York 10029
University of Cincinnati Cincinnati Ohio 45267
Temple University Philadelphia Pennsylvania 19140
Medical University of South Carolina Charleston South Carolina 29425
Baylor College of Medicine Houston Texas 77030
University of Texas HSC, San Antonio San Antonio Texas 78229
University of Virginia, Charlottesville Charlottesville Virginia 22908
INOVA Fairfax Medical Center Fairfax Virginia 22042
Virginia Commonwealth University Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00650858, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00650858 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →